Clearwater Analytics’ Transformative Acquisition of Enfusion Fuels Growth Potential and Market Expansion
In a report released yesterday, Michael Infante from Morgan Stanley maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research ...
KSMU8d
Missouri bills target pharmacy costs, insurance rules on drug pricing
Two bills heard in a state Senate committee are designed to lower prices, provide fair competition for independent pharmacies, backers say.
Business Insider17d
Clearwater Analytics price target lowered to $30 from $36 at RBC Capital
RBC Capital lowered the firm’s price target on Clearwater Analytics (CWAN) to $30 from $36 but keeps an Outperform rating on the shares after its announced Enfusion (ENFN) merger. The addition ...
The Business Journals28d
Developers pay $9.3M for downtown Clearwater site as part of the Bluffs project
Expand to read more Behar + Peteranecz Listen to this article 3 min One of the largest private investments in Clearwater's history is expected to make progress in 2025. The city of Clearwater has ...